ALNY vs SITM · P/E 76, rev $1.29B vs rev $271.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Sitime Corporation (SITM) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Sitime Corporation (SITM) is a semiconductors company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SITM revenue for 2026-06-30 was $271.0M. Net income was $12.9M. SITM currently screens at market cap $5.48B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SITM currently screens at market cap $5.48B.
Not investment advice. Open the ALNY and SITM stock pages for the full models.
Not investment advice.